Histoculture drug response assay to monitor chemoresponse.

Shinji Ohie, Yasuhiro Udagawa, Daisuke Aoki, Shiro Nozawa

研究成果: Article

20 引用 (Scopus)

抜粋

We provide a detailed explanation of the procedure of the histoculture drug response assay (HDRA) with 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide (MTT) end point among several modified HDRA procedures. Fresh surgical specimens are cut into approx 1- to 2-mm3 pieces and put on a gelatin sponge infiltrated with culture medium containing a test drug. After incubation for 7 d, cell viability is assessed by the MTT assay. HDRA uses cancer tissue fragments with cells growing in three dimensions, with maintenance of intercellular contact and interactions with stromal cells. Therefore, it seems that HDRA can assess the sensitivity of tumor cells to anticancer drugs in conditions similar to those in vivo and, consequently, shows high prediction rate.

元の言語English
ページ(範囲)79-86
ページ数8
ジャーナルMethods in molecular medicine
110
出版物ステータスPublished - 2005
外部発表Yes

ASJC Scopus subject areas

  • Molecular Medicine

フィンガープリント Histoculture drug response assay to monitor chemoresponse.' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用